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Background: Subtle, but clinically detectable, neuro-
logical abnormalities (SNAs) are associated with im-
paired physical performance in elderly persons without
overt neurological diseases. We investigated whether SNAs
were prospectively associated with cognitive and func-
tional status, death, and cerebrovascular events (CVEs)
in older community-dwelling individuals.
Methods: In participants without history of stroke, par-
kinsonism and dementia, or cognitive impairment, a score
(NSNA) was obtained by summing SNAs detected with a
simple neurological examination. Cognitive status and
disability were reassessed 4 years later, and deaths and
CVEs were documented over 8 years.
Results: Of 506 participants free of neurological dis-
eases (mean [SEM] age, 71.9[0.3] years; 42% were men),
59% had an NSNA of 1 or more (mean [SEM], 1.1[0.06];
range, 0-8). At baseline, the NSNA increased with age and
with declining cognitive and physical performance, de-
pressive symptoms, and disability, after adjusting for sev-
eral covariates, but did not increase with falls and uri-
nary incontinence. The NSNA prospectively predicted
worsening cognitive status and disability, adjusting for
demographics and for baseline comorbidity and cogni-
tive and physical performance. The mortality rates were
22.6, 23.3, 23.9, 58.6, and 91.9 per 1000 person-years
in participants with an NSNA of 0, 1, 2, 3, and 4 or higher,
respectively. Compared with an NSNA of less than 3, hav-
ing an NSNA of 3 or higher was associated with an in-
creased adjusted risk of death (hazard ratio, 1.77; 95%
confidence interval [CI], 1.25-2.74) and of CVE (haz-
ard ratio, 1.94; 95% CI, 1.07-3.54) over 8 years.
Conclusion: In this sample of older community-
dwelling persons without overt neurological diseases, mul-
tiple SNAs were associated with cognitive and func-
tional decline and independently predicted mortality and
CVEs.
Arch Intern Med. 2008;168(12):1270-1276
S T U D I E S O F A P P A R E N T L Yhealthy, older community-dwelling persons have shownthat subclinical diseases ofdifferent organs are associ-
ated with poor physical performance1,2 and
frailty.3 In the Cardiovascular Health Study
(CHS),4 a lower extent of subclinical car-
diovascular disease predicted successful
aging, defined as the years lived without
physical and cognitive impairment, overt
cardiovascular disease, cancer, and chronic
obstructive pulmonary disease.
In further CHS analyses, the severity of
neurological disease at neuroimaging pre-
dicted accelerated functional decline and
onset of physical dependency.5 Also subtle,
but clinically detectable, neurological ab-
normalities (SNAs) seemed to be associ-
ated with poor physical performance and
falls in a cross-sectional investigation of
818 older community-dwelling persons
without major neurological diseases.6
However, to our knowledge, no study has
ever investigated whether SNAs indepen-
dently predict poor health outcomes in
older persons.
We evaluated whether SNAs are associ-
ated, both cross-sectionally and longitudi-
nally, with reduced cognitive and func-
tional status and falls in older persons free
of overt neurologicaldiseases. We also tested
the association between SNAs and urinary
incontinence, which may be an early mani-
festation of subclinical neurological dis-
ease.7 Finally, we verified whether SNAs in-
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dependently predict mortality and incident cerebrovascular
events (CVEs) over an extended follow-up.
METHODS
STUDY PROTOCOL AND SAMPLE SELECTION
The “Insufficienza Cardiaca negli Anziani Residenti a Dico-
mano” (ICARe Dicomano) study enrolled all the older (65 years)
community-dwelling individuals living in Dicomano, a small ru-
ral town near Florence, Italy. The methods of the study, which
followed the principles of the Declaration of Helsinki, have been
detailed elsewhere.8 Participants gave informed consent. Adher-
ence rates ranged from 91.2% to 80.7% in different phases of the
study. Participants and nonparticipants had similar sex and age
distribution, although slightly fewer men (77.4%) than women
(83.1%) underwent the final clinical assessment.8 From the 1995
baseline study sample, we excluded participants with previous
stroke, parkinsonism, dementia, or cognitive impairment. Par-
ticipants were reinterviewed in 1999. Vital status and hospital-
izations were followed up until December 2003.
DATA COLLECTION
Diagnosis of Overt Neurological Disease
Neurological diseases were identified with standardized algo-
rithms based on previous diagnoses, medical records, struc-
tured medical interviews, and clinical examinations.8 The di-
agnosis of stroke was adjudicated when a previous diagnosis
or positive questionnaire items (deficit in strength in an upper
and/or lower extremity, speech, or visual field) were con-
firmed by hospital discharge records, neuroimaging, or clini-
cal examination. The diagnosis of Parkinson disease or par-
kinsonism was based on clinical examination or a previous
physician’s diagnosis in current specific drug treatment. Par-
ticipants who scored 26 or less on the Mini-Mental State Ex-
amination (MMSE)9 received an extensive neuropsychologi-
cal evaluation by an expert geriatrician, who adjudicated the
final diagnosis of dementia. Conservatively, in the present study
we also excluded participants with cognitive impairment (MMSE
score24) who refused or missed the complete neuropsycho-
logical evaluation necessary to diagnose dementia.
Neurological Clinical Evaluation
The neurological assessment, conducted by expert geriatricians
and summarized in Table 1, required up to 15 minutes and in-
cluded a traditional neurological examination plus 2 simple tests
(ie, dynamometry and the Purdue Pegboard Test).8 Handgrip and
hip flexion strength were assessed on both the right and left sides
with handheld dynamometers, according to a standard proto-
col.10 Consistent with published criteria for lower extremity
strength testing,10 clinically relevant asymmetry for handgrip
strength was defined as a difference of more than 20% between
the 2 sides. In the Purdue Pegboard Test, participants are timed
while putting 10 small sticks into an equal number of holes in a
tablet. Originally introduced to evaluate manual dexterity,11 this
test also explores frontal lobe cognitive function because it re-
quires integrity of attention, sequencing, planning, and motor co-
ordination. We used the score obtained with the dominant hand.
Table 1. Prevalence of SNAs and Their Bivariate Associations With Physical Performance (SPPB Score)
and Cognitive Function (MMSE) in 506 Older Community-Dwelling Persons
Items of the Neurological Evaluation Prevalence, %
P Valuea
SPPB MMSE
Muscle strength–physical examination
Reduced shoulder elevation, detectable difference between the 2 sides while participant is
shrugging against resistance
0.4 .02 .21
Reduced or absent foot extension, detectable difference between the 2 sides while participant
is pushing against resistance (each foot is tested separately)
3.0 .001 .11
Pronator drift or shift of 1 arm while both are extended frontally 0.6 .01 .42
Shift of 1 leg while both hips and knees are flexed at 90° in the supine position 0.0 NA NA
Muscle strength–dynamometry (difference of 20% between the 2 sides)
Handgrip 4.9 .11 .16
Hip flexion 11.3 .66 .49
Sensitivity–physical examination, reduced foot plant sensitivity (light touch) in at least 2 of 3 tests 4.3 .001 .95
Deep tendon reflexes, absent or diminished (present but slightly detectable) muscle contraction
in response to tendon stimulation with a reflex hammer using standard techniques
Absent or reduced patellar reflexes 3.0 .03 .64
Absent or reduced Achilles reflexes 29.9 .002 .01
Plantar (Babinski) reflex, extension of the big toe or fanning of the other toes or contraction
of the fascia lata while rubbing the lateral margin of the sole from heel to toe
3.6 .09 .83
Extrapyramidal signs
Bradykinesia, slowness, reduction in amplitude or arrest during thumb-finger tapping, hand
movements (opening-closing, pronosupination), heel tapping, or arising from a chair
0.2 .14 .01
Resting tremor while the participant is relaxed, with both hands resting in the lap 3.6 .02 .01
Muscle rigidity, steady resistance throughout the entire range of movement at passive rotation
of the neck and flexion and extension of elbows and knees
2.4 .001 .001
Postural instability–retropulsion at the pull test 20.0 .02 .01
Superior functions
Frontal lobe function (Purdue Pegboard Test)–dominant hand 9.1 .001 .001
Abbreviations: MMSE, Mini-Mental State Examination; NA, not applicable; SNAs, subtle neurological abnormalities; SPPB, Short Physical Performance Battery.
aP values indicate significant differences in mean SPPB and mean MMSE between participants with and without each specific subtle neurological abnormality.
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Failure to complete the task, or a time to complete above the 90th
percentile of the study sample, indicated an altered perfor-
mance. The reliability of the neurological examination had been
previously evaluated in a small sample of older outpatients with
characteristics similar to participants in the present survey. For
the standard neurological examination, interrater agreement in
the distinction between normal vs abnormal findings was very
high ( 0.95). Other items, based on continuous measures (eg,
muscle strength) initially reported greater variability, which, af-
ter training and standardization, was contained to an interrater
difference of 10% to 15%.
To obtain a final score of neurological damage, we calcu-
lated, for each participant, the number of SNAs (NSNA) de-
tected with the neurological examination (defined as “subtle”
because they neither related to definite neurological diseases
nor were reported by the participants).
Covariates
Functional Status. Functional status was measured as self-
reported disability in the activities of daily living (ADLs)
and, objectively, using the Short Physical Performance Battery
(SPPB) for lower extremities12 and the 6-minute walking test
(6MWT).13 According to a modified version of the World Health
Organization questionnaire,8,14 severity of disability was ex-
pressed as the number of basic and instrumental ADLs (BADLs
and IADLs, respectively) in which the participant was depen-
dent. The BADLs included 6 tasks: walking in the house, wash-
ing (hands and face), dressing oneself, toileting, transferring
from bed to chair, and eating. The IADLs included 9 tasks: walk-
ing outside, walking 400 m without rest, climbing stairs, shop-
ping, bathing or showering, cooking, housekeeping (both light
and heavy tasks), and trimming nails.
Themodifiedversionof theSPPBused in this study15 included
3subtests, forbalance(standing in5tasksof increasingdifficulty),
walking (4-m gait speed), and muscle strength (time to stand up
5 times from a chair). In the ICARe Dicomano study population,
the SPPB summary score (range, 0-12, where 0 is worst perfor-
mance and 12 is the best) predicted disability and death.16
Sustainable walking capacity was assessed with the 6MWT,13
which measures the distance walked in 6 minutes at the pre-
ferred velocity and represents a valid and reliable indicator of
physical performance in elderly persons.17,18
Falls and Urinary Incontinence. Specific questionnaires were
used to evaluate the number of falls in the preceding 12 months
(0, 1-2, and 3 falls) and urge urinary incontinence (never,
rare, or persistent).8
Cognitive and Emotional Status. Cognitive status was as-
sessed with the MMSE9; depressive symptoms, with the Geri-
atric Depression Scale.19
Comorbidity.Comorbidity was measured with the Index of Co-
existent Diseases, calculated as the sum of individual severity
scores assigned to 14 chronic conditions, which were identi-
fied with structured diagnostic algorithms.16,20
Follow-up. In1999,cognitivestatus,ADLdisability,andfallswere
assessed using the same instruments as in 1995. Vital status and
hospital admissions forCVEthrough2003wereascertainedusing
administrative databases of the Tuscany region of Italy.
STATISTICAL ANALYSIS
Continuous variables are expressed as mean (SEM), and t tests
were used to examine differences in MMSE and SPPB between
participants with and those without each SNA. Differences in
baseline characteristics across increasing NSNA were assessed with
the 2 test for trend for categorical variables and with analysis
of variance (ANOVA) (or analysis of covariance [ANCOVA],
to adjust for age and sex) for continuous variables. Multivari-
able logistic regression was used to evaluate the association be-
tween NSNA, taken as the independent variable in a cross-
sectional design, and the prevalence of falls (0 vs1) and urinary
incontinence (never vs rare or persistent), adjusting for age
and sex.
The ANOVA (or ANCOVA, when continuous variables were
entered as covariates) was used to model the longitudinal as-
sociations between NSNA and declines in functional status (dif-
ference in the number of limitations in BADL and IADL from
1995 to 1999), cognitive status (change in MMSE from 1995
to 1999), and falls in the 12 months preceding the follow-up
evaluation. Age, sex, comorbidity, SPPB, MMSE, and disabil-
ity were entered in the models as covariates. Polynomial con-
trasts were applied to test for linear trends between contigu-
ous categories of the NSNA (0, 1, 2, 3, and 4).
Cox proportional hazards regression models were used to
evaluate NSNA as a predictor of death and hospitalization for CVE,
adjusting for age, sex, comorbidity, SPPB, MMSE, BADL, IADL,
and, limited to the outcome of CVE, for previous transient is-
chemic attacks. Because mortality rates seemed to sharply in-
crease for NSNA values of 3 or higher, this was used as a cutoff
point in survival analyses. Age and sex were forced in the model,
whereas NSNA (3 vs3) and the other baseline variables were
entered at the first step and backward deleted thereafter (P=.05).
Additional Cox models were constructed to examine the effect
of adding NSNA to age, sex, comorbidity, and functional and cog-
nitive status in the prediction of either death or CVE. For each
outcome, the statistical significance of the difference between
the −2 log likelihood of 2 models, 1 without and the other with
NSNA, was tested against a 24 distribution (P .05) to deter-
mine the improvement of the models after the inclusion of NSNA.
A 2-tailed P.05 was considered statistically significant.
Analyses were performed using SPSS statistical software (ver-
sion 12.0; SPSS Inc, Chicago, Illinois).
RESULTS
BASELINE EVALUATION
Of 864 eligible participants, 697 underwent baseline clini-
cal evaluation.7 Exclusion of 118 participants with his-
tory of stroke, parkinsonism, dementia, or cognitive im-
pairment, and of another 73 with incomplete data led to
a final sample of 506 participants (mean [SD] age,
72.5[0.3] years; 57% were women). Participants ex-
cluded owing to incomplete data were older (77.5[0.9]
years; P .001) than those included but did not differ
in sex, BADL disability, severity of comorbidity, or level
of physical performance (data not shown).
Of the 15 neurological signs considered, 5 were as-
sociated only with the SPPB, 1 only with the MMSE, and
5 with both tests (Table 1). The 2 most prevalent SNAs
were reduced Achilles reflexes and postural instability.
The greatest observed NSNA was 8 (mean [SD], 1.1[0.06]),
in a possible range of 0 to 19 (considering that 4 signs
could be bilateral). The number of participants with an
NSNA of 0, 1, 2, 3, and 4 or more was 208, 131, 96, 38,
and 33, respectively. The mean age increased across NSNA
levels, whereas the proportion of women was similar
(Table 2). Comorbidity increased with higher NSNA in
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unadjusted comparisons (P .001; data not shown), al-
though after adjusting for age and sex the linear trend
was no longer significant (P=.08) (Table 2). After con-
trolling for age and sex, an increasing NSNA was associ-
ated with a greater severity of IADL disability, more de-
pressive symptoms, and worse cognitive and functional
status (Table 2).
In bivariate comparisons, increasing NSNA was also as-
sociated with more falls in the previous year (2=4.46;
P value for trend=.04) and with more frequent urge uri-
nary incontinence (2=5.88; P value for trend=.02). Af-
ter adjusting for age and sex, these associations were no
longer statistically significant (P value for trend=.12 for
falls; P value for trend=.47 for urinary incontinence).
LONGITUDINAL ANALYSIS
In 1999, 420 of the original 506 participants were rein-
terviewed. Increasing NSNA predicted 4-year functional and
cognitive decline, expressed as the number of BADLs and
IADLs lost, and the reduction in MMSE score between
baseline and follow-up, respectively. The analyses were
adjusted for age, sex, and baseline comorbidity, SPPB,
MMSE, and BADL and IADL (Figure 1). In bivariate
analysis, NSNA predicted the number of falls in the 12
months preceding the 1999 evaluation (P=.03). This re-
sult was no longer significant after adjustment for de-
mographics and comorbidity (P=.13).
From 1995 through 2003, 113 participants died and
62 were hospitalized for CVE. The mortality rates were
22.6, 23.3, 23.9, 58.6, and 91.9 per 1000 person-years
in participants with an NSNA of 0, 1, 2, 3, and 4 or greater,
respectively. Compared with a value of less than 3, hav-
ing an NSNA of 3 or greater was associated with a 2-fold
greater risk of death (hazard ratio [HR], 1.77; 95% con-
fidence interval [CI], 1.25-2.74, adjusted for age, sex, base-
line comorbidity, SPPB, MMSE, and BADL and IADL) and
CVE (HR, 1.94; 95% CI, 1.07-3.54, adjusted also for his-
tory of transient ischemic attacks) (Figure 2). When
added to age, sex, comorbidity, cognitive and physical
functions, and functional status in Cox models, NSNA im-
proved the prediction of mortality (P =.006 for the like-
lihood ratio test), whereas the improvement of the model
Table 2. Demographic and Clinical Characteristics of 506 Older Participants, by NSNA
Characteristic
NSNA, No. of Participantsa
P Value
0
(n = 208)
1
(n = 131)
2
(n = 96)
3
(n = 38)
4
(n = 33)
Age, yb 71.2 ± 0.4 71.2 ± 0.4 73.7 ± 0.5 73.9 ± 1.1 78.1 ± 1.2 .001
Women, No. (%) 113 (54.3) 77 (58.8) 54 (56.3) 26 (68.9) 17 (51.5) .52
ICEDc 6.5 ± 0.2 7.1 ± 0.3 7.5 ± 0.3 7.5 ± 0.5 7.6 ± 0.5 .08
MMSE scorec 26.9 ± 0.1 26.8 ± 0.2 26.7 ± 0.2 26.4 ± 0.3 25.6 ± 0.4 .003
GDS scorec 6.6 ± 0.4 8.6 ± 0.6 8.0 ± 0.6 8.9 ± 1.0 8.9 ± 1.0 .047
SPPB scorec 9.8 ± 0.1 9.5 ± 0.1 9.5 ± 0.1 8.9 ± 0.1 7.4 ± 0.1 .001
6-MWTc 344 ± 91 326 ± 79 311 ± 91 306 ± 90 253 ± 93 .001
BADLs, No. with dependencyb 0.02 ± 0.02 0.05 ± 0.03 0.07 ± 0.04 0.06 ± 0.05 0.06 ± 0.06 .50
IADLs, No. with dependencyb 0.3 ± 0.08 0.4 ± 0.10 0.6 ± 0.11 0.6 ± 0.16 1.4 ± 0.21 .001
Abbreviations: 6-MWT, walking distance during a 6-minute walking test; BADL, basic activity of daily living; IADL, instrumental activity of daily living;
GDS, Geriatric Depression Scale; ICED, Index of Coexistent Diseases; MMSE, Mini-Mental State Examination; NSNA, number of subtle neurological abnormalities;
SPPB, Short Physical Performance Battery score.
aData are given as mean ± SEM except where noted.
bUnadjusted means from analysis of variance models.
cMeans adjusted for age and sex from analysis of covariance models.
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Figure 1. Prediction of functional and cognitive decline from 1995 to 1999 in
420 older community-dwelling persons free of overt neurological diseases at
baseline. All analyses adjusted for age, sex, baseline comorbidity, physical
performance, cognitive functioning, and basic and instrumental activities of
daily living (BADLs and IADLs, respectively). NSNA indicates the number of
subtle neurological abnormalities; the error bars indicate the mean±SE.
A, BADL analysis; B, IADL analysis; C, Mini-Mental State Examination
(MMSE) analysis.
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predicting CVE did not reach statistical significance
(P =.08 for the likelihood ratio test).
COMMENT
In our sample of older community-dwelling persons free
of overt neurological diseases, a standardized examina-
tion disclosed at least 1 SNA in more than half of the par-
ticipants, with a prevalence increasing with age. A strong
and independent association was demonstrated cross-
sectionally among the NSNA and IADL disability, worse
cognitive and physical performances, and more depres-
sive symptoms. In longitudinal analyses, the NSNA pre-
dicted functional and cognitive decline over 4 years and
mortality and CVE over 8 years.
Despite some differences in the neurological exami-
nation, our baseline results reinforce those obtained in
a similar population-based, cross-sectional study of older
persons.6 In both investigations, a mean number of ap-
proximately 1.1 SNAs was detected, with similar asso-
ciations among the NSNA and physical performance and
falls. Compared with the previous report, the present
analysis has a more accurate control for covariates. More-
over, the longitudinal design provides support to the hy-
pothesis of a causal relationship among the NSNA and func-
tional and cognitive decline, death, and CVE. To our
knowledge, this is the first study showing this associa-
tion prospectively in a relatively large sample of unse-
lected elderly persons. A previous report21 was limited
in terms of number of participants (only 59), setting (clini-
cal selection), and signs tested (tendon reflexes and vi-
bration sense).
Performance-based tests for cognitive and physical
functions and depressive symptoms are relevant clinical
markers of cardiorespiratory, skeletal, muscular, and ner-
vous functions and predict subsequent disability, CVE,
and mortality in apparently healthy older adults.12,22-25 In
the present study, SNA predicted cognitive and func-
tional decline, CVE, and mortality independent of all these
other measures of cognitive function, physical perfor-
mance, and mood. Thus, a simple neurological exami-
nation seems to be an additional prognosticator of hard
outcomes, particularly death, above and beyond other
measures used in clinical practice. It is likely that the neu-
rological examination might capture additional infor-
mation about the integrity of the nervous system in
apparently healthy older adults.
A previous study26 documented the relationship be-
tween specific SNA and diffuse brain white matter le-
sions using computed tomographic scans in older adults
without dementia. Similarly, in CHS participants with-
out a history of stroke, the number of neurological find-
ings was independently associated with silent infarc-
tions at brain magnetic resonance imaging.27 In turn,
neuroimaging evidence of subclinical brain disease is as-
sociated with cognitive decline, executive dysfunction,
depression, gait disorders, falls, urinary incontinence,7
poor physical performance,5,28 and incident ADL depen-
dency.29 Subclinical brain disease also predicts CVE30 and
mortality31 in elderly individuals. Thus, we speculate that
our findings reflect the presence of diffuse white matter
lesions or brain infarcts. However, although most of the
neurological signs included in the NSNA could be an ex-
pression of damage in the central nervous system, some
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Figure 2. Cumulative survival and cumulative event-free survival during the follow-up period. Mortality (A) and incident hospitalization for cerebrovascular events
(B) in 506 older community-dwelling persons free of overt neurological diseases, by number of subtle neurological abnormalities (NSNA) (3 vs 3). Cox
proportional hazard models were adjusted for age, sex, baseline comorbidity, cognitive and physical performance, and functional status at baseline (A and B) and
history of transient ischemic attacks (B). CI indicates confidence interval; HR, hazard ratio.
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of them may be caused by peripheral neuropathy, a con-
dition that can indeed contribute to physical perfor-
mance decline in elderly persons.32
Our results suggest a nonlinear relationship between
NSNA and the long-term hard outcomes of death and
CVE, the risk of which dramatically increased in the
presence of 3 or more SNAs. The absence of a dosage-
response relationship does not exclude per se causa-
tion. Rather, a given level of neurological damage, up to
a critical threshold, might be required before overt con-
sequences become apparent. This threshold effect
might reflect, for example, diffuse or confluent white
matter hyperintensities rather than isolated lesions. Al-
ternatively, it is possible that the associations we found
were driven only by a limited number of specific neuro-
logical abnormalities, which more likely occurred when
more SNAs were detected. Given the limited sample
size, we could not discriminate between these alterna-
tives; further studies are needed to confirm these find-
ings and to highlight their pathogenesis and conse-
quences.
Additional study limitations must be considered. First,
our clinical summary score of neurological damage is
probably less sensitive and specific than neuroimaging,
and, therefore, it is of limited value in etiologic studies.
Nevertheless, because of its low cost and ease of use, it
might prove useful in clinical practice and in epidemio-
logic studies. Second, we were unable to prospectively
investigate the association between SNAs and changes in
physical performance because the SPPB and the 6MWT
were not reassessed during the follow-up.
With these limitations in mind, our findings indicate
that SNAs are frequent and must be systematically in-
vestigated in elderly persons. Subtle neurological ab-
normalities can be used to reveal otherwise undetected
brain damage with relevant functional correlates and a
clear prognostic value on survival and the development
of CVE. Moreover, should the hypothesized association
with cerebrovascular disease be demonstrated in future
studies, the detection of multiple SNAs might prompt
further cardiovascular investigation and eventually lead
to a more intensive management of cardiovascular risk
factors.
Our data support the hypothesis that SNAs in elderly
individuals are a manifestation of early brain damage, a
finding that may have important implications in re-
search studies on the prevention of age-related cogni-
tive and functional decline. Understanding the nature of
dysfunctions underlying the decline in physical perfor-
mance and disability contributes to planning specific pre-
ventive interventions. If our findings are confirmed by
future research, NSNA might be also considered as a sur-
rogate outcome for such intervention studies.
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Correction
Errors in Abstract and Text. In the Original Investiga-
tion by Fung et al titled “Adherence to a DASH-Style Diet
and Risk of Coronary Heart Disease and Stroke in
Women,” published in the April 14, 2008, issue of the
Archives (2008;168[7]:713-720), 2 errors occurred in the
text. On page 713, in the first sentence of the “Results”
section in the abstract, the number of cases of stroke is
incorrect. The corrected sentence reads as follows: “We
documented 2129 cases of incident nonfatal myocar-
dial infarction, 976 CHD deaths, and 2317 cases of
stroke.” On page 715, in the first sentence of the “Re-
sults” section, the number of cases of CHD is incorrect.
The corrected sentence reads as follows: “During 24 years
of follow-up, we documented 3105 cases of CHD, of
which 2129 were nonfatal and 976 fatal, and 2317 cases
of stroke, of which 1242 were ischemic and 400 hem-
orrhagic (the remainder could not be clearly classified).”
(REPRINTED) ARCH INTERN MED/ VOL 168 (NO. 12), JUNE 23, 2008 WWW.ARCHINTERNMED.COM
1276
©2008 American Medical Association. All rights reserved.
 at UNIEVERSITA DEGLI STUDI DI FIRENZE, on May 2, 2012 www.archinternmed.comDownloaded from 
